Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-13Clinical Trial Update: BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors [Phase 1]
A Phase 1 trial evaluating BGB-A3055 alone and in combination with tislelizumab for solid tumors was terminated.
-
CLINICAL_TRIALS withdrawal · 2026-01-06Clinical Trial Update: Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating immune reconstitution monitoring and pneumococcal vaccination in patients treated with CAR-T cells has be…
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
The LB101 study in participants with advanced solid tumors (Phase 1/2) was terminated.
-
CLINICAL_TRIALS withdrawal · 2025-07-17Clinical Trial Update: A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors [Phase 1]
This clinical trial update indicates the Phase 1, first-in-human study of GENA-104A16 in patients with advanced solid tumors has been withdr…
-
CLINICAL_TRIALS withdrawal · 2025-04-08Clinical Trial Update: A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01) [Phase 1, Phase 2]
A pediatric/young adult trial evaluating pembrolizumab with investigational agents for hematologic malignancies or solid tumors has been wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-04-01Clinical Trial Update: A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating potential drug interactions between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in patients with advan…
-
CLINICAL_TRIALS withdrawal · 2025-01-07Clinical Trial Update: Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial of Nab-Paclitaxel in combination with STI-3031 Complex (AP160-Complex) for advanced or metastatic solid tumors has been with…
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors [Phase 1]
The Phase 1 study of SPX-101 in adults with advanced or refractory solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-15Clinical Trial Update: ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors [Phase 1]
A Phase 1 trial evaluating ZEN003694 in combination with niraparib for metastatic or recurrent solid tumors, including ovarian cancer, has b…
-
CLINICAL_TRIALS withdrawal · 2024-05-08Clinical Trial Update: A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
The phase 1/2 trial of MDK-703 in patients with solid tumors has been terminated.
-
CLINICAL_TRIALS withdrawal · 2023-09-28Clinical Trial Update: A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia [Phase 3]
Phase 3 clinical trial of Hetrombopag Olamine Tablets for chemotherapy-induced thrombocytopenia in solid tumour patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-27Clinical Trial Update: Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies [Phase 1]
This Phase 1 trial of alisertib (MLN8237) in combination with brentuximab vedotin for relapsed/refractory CD30-positive lymphomas and CD30-p…
-
CLINICAL_TRIALS withdrawal · 2018-03-21Clinical Trial Update: Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers [Phase 1]
Phase 1 trial evaluating mesenchymal stem cells for cisplatin-induced acute kidney injury in patients with solid tumors; the study status is…
-
CLINICAL_TRIALS withdrawal · 2017-05-15Clinical Trial Update: Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) [Phase 2]
Phase 2 trial evaluating SharkCore EUS-guided biopsy needle versus ProCore has been withdrawn. Sponsor: Johns Hopkins University; conditions…
-
CLINICAL_TRIALS withdrawal · 2015-10-07Clinical Trial Update: A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study of PF-03084014 in Japanese patients with advanced solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-17Clinical Trial Update: MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) [Phase 1]
A Phase 1 study of MK0457, an Aurora kinase inhibitor, in patients with advanced colorectal cancer and other advanced solid tumors was termi…
-
CLINICAL_TRIALS withdrawal · 2015-06-16Clinical Trial Update: Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
The Phase 1 trial evaluating a single dose of intravenous recombinant human TNF-α with liposomal doxorubicin in patients with advanced solid…
-
CLINICAL_TRIALS withdrawal · 2015-02-16Clinical Trial Update: Ph Ib/BGJ398/Cervix and Other Solid Tumors [Phase 1]
A Phase Ib trial of BGJ398 in cervical cancer and other solid tumors was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-10Clinical Trial Update: A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors [NA]
This update reports the withdrawal of a Phase I trial of AVN944, an IMPDH inhibitor, in adults with advanced solid tumors.
-
CLINICAL_TRIALS withdrawal · 2013-08-28Clinical Trial Update: Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas [Phase 1]
The Phase 1 GMX1777 trial for refractory solid tumors or lymphomas has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel
A clinical trial investigating biomarkers related to muscle and joint pain in patients with solid tumors receiving paclitaxel has been termi…
-
CLINICAL_TRIALS withdrawal · 2012-11-21Clinical Trial Update: Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma [Phase 1]
Phase 1 trial of imetelstat in children with refractory or recurrent solid tumors or lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: TTP607 in Refractory Solid Malignancies [Phase 1]
Phase 1 trial of TTP607 for advanced cancers and lymphoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-11Clinical Trial Update: KRN7000 in Treating Patients With Solid Tumors [Phase 1]
A Phase 1 trial investigating KRN7000 for solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-25Clinical Trial Update: Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) [Phase 1]
Phase 1 extension evaluating patupilone's effect on the pharmacokinetics of midazolam and omeprazole in patients with advanced solid tumors …